Ocugen, Inc. — Director's Dealing 2021

Apr 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2021-04-19

Reporting Person: Kumar Ramesh (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-19	Common Stock	M	7500	$0.510	Acquired	7500	Direct
2021-04-19	Common Stock	S	7500	$5.33	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-19	Option (Right to Buy)	$0.51	M	7500	Disposed	2030-01-02	Common Stock (7500)	Direct

Footnotes

F1: This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.29 to $5.37.

F3: The options vested monthly in equal installments over three years commencing on February 2, 2020, subject to continued service with the Company on the applicable vesting dates.